CTLA4Ig: effects on cellular and humoral immunity and macrophage activation.
Schaub
M
M
Laboratory of Immunogenetics and Transplantation, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass. 02115, USA.
Stadlbauer
T H
TH
Sayegh
M H
MH
D000069594:Abatacept; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000494:pharmacology*; D015551:Autoimmunity; D060908:CTLA-4 Antigen; D006085:Graft Survival; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects*; D018796:Immunoconjugates; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008262:Macrophage Activation / Q000187:drug effects*; D011993:Recombinant Fusion Proteins
D015703:Antigens, CD; D000943:Antigens, Differentiation; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D011993:Recombinant Fusion Proteins; D000069594:Abatacept